Paper29248564
EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2.
Klipp RC and 7 others. Heart Rhythm, 2018. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. EL20, a potent antiarrhythmic compound, selectively inhibits calmodulin-deficient ryanodine receptor type 2. Papers, record 29248564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/29248564
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Arrhythmia Agents | Major topic |
| Calmodulin | Major topic |
| DNA | Major topic |
| Mutation | Major topic |
| Myocytes, Cardiac | Major topic |
| Ryanodine Receptor Calcium Release Channel | Major topic |
| Tachycardia, Ventricular | Major topic |
| Animals | |
| Calcium | |
| DNA Mutational Analysis | |
| Disease Models, Animal | |
| Mice | |
| Mice, Mutant Strains | |
| Sarcoplasmic Reticulum | |
| Sheep | |
| Polymorphic Catecholaminergic Ventricular Tachycardia |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R42 HL114206 | NHLBI NIH HHS | United States | R42HL114206 | PubMed and NIH | NIH RePORTER |
| R41 HL129570 | NHLBI NIH HHS | United States | R41HL129570 | PubMed and NIH | NIH RePORTER |
| R01 HL136389 | NHLBI NIH HHS | United States | R01HL136389 | PubMed and NIH | NIH RePORTER |
| R01 HL091947 | NHLBI NIH HHS | United States | R01HL091947 | PubMed and NIH | NIH RePORTER |
| R01 HL089598 | NHLBI NIH HHS | United States | R01HL089598 | PubMed and NIH | NIH RePORTER |
| R01 HL117641 | NHLBI NIH HHS | United States | R01HL117641 | PubMed and NIH | NIH RePORTER |
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 29410362 | Tetracaine derivatives for catecholaminergic polymorphic ventricular tachycardia: New drugs for correction of diastolic Ca2+ leak? | https://conductscience.org/library/papers/29410362 |
Source PubMed
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12386154 | Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia. | Circ Res | 2002 | https://conductscience.org/library/papers/12386154 | PubMed |
| 2 | 12707260 | Molecular basis of calmodulin binding to cardiac muscle Ca(2+) release channel (ryanodine receptor). | J Biol Chem | 2003 | https://conductscience.org/library/papers/12707260 | PubMed |
| 3 | 22158709 | Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. | Circ Res | 2012 | https://conductscience.org/library/papers/22158709 | PubMed |
| 4 | 25920678 | Essential Role of Calmodulin in RyR Inhibition by Dantrolene. | Mol Pharmacol | 2015 | https://conductscience.org/library/papers/25920678 | PubMed |
| 5 | 21616285 | Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. | J Am Coll Cardiol | 2011 | https://conductscience.org/library/papers/21616285 | PubMed |
| 6 | 20226167 | Defective calmodulin binding to the cardiac ryanodine receptor plays a key role in CPVT-associated channel dysfunction. | Biochem Biophys Res Commun | 2010 | https://conductscience.org/library/papers/20226167 | PubMed |
| 7 | 24186966 | Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure. | Circ Res | 2014 | https://conductscience.org/library/papers/24186966 | PubMed |
| 8 | 8175760 | Reconstitution of the skeletal muscle ryanodine receptor-Ca2+ release channel protein complex into proteoliposomes. | J Biol Chem | 1994 | https://conductscience.org/library/papers/8175760 | PubMed |
| 9 | 17431507 | Early cardiac hypertrophy in mice with impaired calmodulin regulation of cardiac muscle Ca release channel. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17431507 | PubMed |
| 10 | 14747315 | Mechanism of calmodulin inhibition of cardiac sarcoplasmic reticulum Ca2+ release channel (ryanodine receptor). | Biophys J | 2004 | https://conductscience.org/library/papers/14747315 | PubMed |
| 11 | 12919952 | Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. | Circ Res | 2003 | https://conductscience.org/library/papers/12919952 | PubMed |
| 12 | 12069756 | Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/isoleucine zippers. | Trends Cardiovasc Med | 2002 | https://conductscience.org/library/papers/12069756 | PubMed |
| 13 | 12445877 | The cardiac ryanodine receptor (calcium release channel): emerging role in heart failure and arrhythmia pathogenesis. | Cardiovasc Res | 2002 | https://conductscience.org/library/papers/12445877 | PubMed |
| 14 | 1621949 | Bound and determined: a computer program for making buffers of defined ion concentrations. | Anal Biochem | 1992 | https://conductscience.org/library/papers/1621949 | PubMed |
| 15 | 20388639 | Dissociation of calmodulin from cardiac ryanodine receptor causes aberrant Ca(2+) release in heart failure. | Cardiovasc Res | 2010 | https://conductscience.org/library/papers/20388639 | PubMed |
| 16 | 27318036 | CaMKII-dependent phosphorylation of RyR2 promotes targetable pathological RyR2 conformational shift. | J Mol Cell Cardiol | 2016 | https://conductscience.org/library/papers/27318036 | PubMed |
| 17 | 17588328 | Ryanodine receptors as pharmacological targets for heart disease. | Acta Pharmacol Sin | 2007 | https://conductscience.org/library/papers/17588328 | PubMed |
| 18 | 16873551 | Mice with the R176Q cardiac ryanodine receptor mutation exhibit catecholamine-induced ventricular tachycardia and cardiomyopathy. | Proc Natl Acad Sci U S A | 2006 | https://conductscience.org/library/papers/16873551 | PubMed |
| 19 | 27838126 | Treatment of catecholaminergic polymorphic ventricular tachycardia in mice using novel RyR2-modifying drugs. | Int J Cardiol | 2017 | https://conductscience.org/library/papers/27838126 | PubMed |
| 20 | 22067155 | FRET detection of calmodulin binding to the cardiac RyR2 calcium release channel. | Biophys J | 2011 | https://conductscience.org/library/papers/22067155 | PubMed |
Cited by19
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39835466 | Genetics, manifestations, and management of catecholaminergic polymorphic ventricular tachycardia. | Curr Opin Cardiol | 2025 | https://conductscience.org/library/papers/39835466 | PubMed |
| 38855953 | Development of Ryanodine Receptor (RyR) Inhibitors for Skeletal Muscle and Heart Diseases. | Juntendo Iji Zasshi | 2023 | https://conductscience.org/library/papers/38855953 | PubMed |
| 38542006 | Catecholaminergic Polymorphic Ventricular Tachycardia: Clinical Characteristics, Diagnostic Evaluation and Therapeutic Strategies. | J Clin Med | 2024 | https://conductscience.org/library/papers/38542006 | PubMed |
| 38205355 | Mind the Gap: Does Junctophilin 2 Gear the Coupled-Clock System in Pacemaker Cardiomyocytes? | JACC Basic Transl Sci | 2023 | https://conductscience.org/library/papers/38205355 | PubMed |
| 38205351 | Junctional Ectopic Tachycardia Caused by Junctophilin-2 Expression Silencing Is Selectively Sensitive to Ryanodine Receptor Blockade. | JACC Basic Transl Sci | 2023 | https://conductscience.org/library/papers/38205351 | PubMed |
| 37387319 | RYR2-ryanodinopathies: from calcium overload to calcium deficiency. | Europace | 2023 | https://conductscience.org/library/papers/37387319 | PubMed |
| 36706317 | Reduction in Junctophilin 2 Expression in Cardiac Nodal Tissue Results in Intracellular Calcium-Driven Increase in Nodal Cell Automaticity. | Circ Arrhythm Electrophysiol | 2023 | https://conductscience.org/library/papers/36706317 | PubMed |
| 36369981 | Repeatability of ventricular arrhythmia characteristics on the exercise-stress test in RYR2-mediated catecholaminergic polymorphic ventricular tachycardia. | Europace | 2023 | https://conductscience.org/library/papers/36369981 | PubMed |
| 35677449 | Structural Insight Into Ryanodine Receptor Channelopathies. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35677449 | PubMed |
| 35457253 | Therapeutic Approaches of Ryanodine Receptor-Associated Heart Diseases. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35457253 | PubMed |
| 35426759 | Targeting calcium-mediated inter-organellar crosstalk in cardiac diseases. | Expert Opin Ther Targets | 2022 | https://conductscience.org/library/papers/35426759 | PubMed |
| 34110090 | Efficacy of RyR2 inhibitor EL20 in induced pluripotent stem cell-derived cardiomyocytes from a patient with catecholaminergic polymorphic ventricular tachycardia. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/34110090 | PubMed |
| 33399957 | Mechanisms underlying pathological Ca2+ handling in diseases of the heart. | Pflugers Arch | 2021 | https://conductscience.org/library/papers/33399957 | PubMed |
| 32832689 | Structural mechanism of two gain-of-function cardiac and skeletal RyR mutations at an equivalent site by cryo-EM. | Sci Adv | 2020 | https://conductscience.org/library/papers/32832689 | PubMed |
| 32678103 | Inherited cardiac arrhythmias. | Nat Rev Dis Primers | 2020 | https://conductscience.org/library/papers/32678103 | PubMed |
| 31869254 | Targeting pathological leak of ryanodine receptors: preclinical progress and the potential impact on treatments for cardiac arrhythmias and heart failure. | Expert Opin Ther Targets | 2020 | https://conductscience.org/library/papers/31869254 | PubMed |
| 30904562 | Channelopathies - An update 2018. | Indian Pacing Electrophysiol J | 2019 | https://conductscience.org/library/papers/30904562 | PubMed |
| 30374311 | Arrhythmogenic Mechanisms in Heart Failure: Linking β-Adrenergic Stimulation, Stretch, and Calcium. | Front Physiol | 2018 | https://conductscience.org/library/papers/30374311 | PubMed |
| 29410362 | Tetracaine derivatives for catecholaminergic polymorphic ventricular tachycardia: New drugs for correction of diastolic Ca2+ leak? | Heart Rhythm | 2018 | https://conductscience.org/library/papers/29410362 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| RYR2 | 6262 | PubTator's text mining | https://conductscience.org/library/genes/6262 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/29248564
GET https://conductscience.org/api/papers/v1/29248564/references?page=2